Company Filing History:
Years Active: 1979-1980
Title: Mitsugu Itoh: Innovator in Antibiotic Development
Introduction
Mitsugu Itoh is a prominent inventor based in Machida, Japan. He has made significant contributions to the field of antibiotic research, holding a total of 2 patents. His work focuses on the development of novel antibiotics that have the potential to combat bacterial infections.
Latest Patents
Itoh's latest patents include the "Novel antibiotic BN-213 substance and its production" and the "Antibiotic BN-200 substance and process for production thereof." The first patent describes a BN-213 substance-producing strain of the genus Pseudomonas that is cultivated to produce the BN-213 substance in a culture medium. This substance is then isolated and purified, proving to be a novel antibiotic. The second patent details the production of an antibiotic BN-200 substance, which is achieved by cultivating a BN-200 substance strain of the genus Erwinia.
Career Highlights
Mitsugu Itoh is associated with Meiji Seika Kaisha, Ltd., a company known for its commitment to innovation in the pharmaceutical industry. His work has contributed to the advancement of antibiotic therapies, addressing the growing concern of antibiotic resistance.
Collaborations
Itoh has collaborated with notable colleagues such as Shinji Miyadoh and Norio Ezaki, enhancing the research and development efforts within his field.
Conclusion
Mitsugu Itoh's innovative work in antibiotic development showcases his dedication to improving healthcare through scientific research. His patents reflect a commitment to finding new solutions to pressing medical challenges.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.